Healthcare & Life Sciences
Financial clarity for organizations focused on care and discovery.
Healthcare and life sciences organizations face reimbursement timing, capital demands, and reporting complexity. Our role is financial.
How money moves through healthcare and life sciences
Reimbursement and payer mix
Most provider revenue depends on what payers agree to pay, not list prices.
Read more: Reimbursement and payer mix
Healthcare providers bill charges, but revenue is determined by contracted rates with commercial insurers, government program fee schedules, and patient payments. Payer mix, the proportion of revenue from each source, strongly influences margin. Denials, underpayments, and changes in coverage rules affect cash collected. Revenue cycle performance, from registration through coding, billing, and collections, determines how much earned revenue actually becomes cash and how quickly.
Labor-intensive cost structure
Clinical and support staff are the largest and least flexible cost.
Read more: Labor-intensive cost structure
Providers depend on physicians, nurses, therapists, technicians, and administrative staff, and compensation is typically the largest expense. Shortages in key roles drive premium pay, contract labor, and overtime. Staffing levels are often tied to patient volume and regulatory requirements, so costs cannot be reduced quickly when volume falls. Productivity measures that link staffing to volume and revenue are essential to managing margin.
Development-stage capital in life sciences
Biotech and medical technology companies spend years before commercial revenue.
Read more: Development-stage capital in life sciences
Pharmaceutical, biotechnology, and medical technology companies invest in research, clinical trials, and regulatory submissions long before products generate revenue. Funding comes from venture capital, public markets, partnerships, and grants, and spending is organized around milestones. Runway planning must reflect trial timelines, regulatory uncertainty, and the cost of manufacturing scale-up. Commercial-stage companies face reimbursement and market access questions as well.
Financial advisory, not clinical services
The firm advises on finance and operations, never clinical practice.
Read more: Financial advisory, not clinical services
This sector covers financial, operational, and capital advisory to healthcare providers, services companies, and life sciences businesses. Perrin & Co. does not provide clinical, medical, coding certification, regulatory, or legal services, and it does not advise on patient care. Reimbursement analysis addresses the financial effect of payer contracts and revenue cycle performance. Clinical and compliance questions remain with qualified professionals and counsel.
Where healthcare organizations feel financial pressure
Revenue cycle leakage
Denials and underpayments reduce cash from services already delivered.
Read more: Revenue cycle leakage
Errors in registration, eligibility verification, coding, and claims submission lead to denials and delayed payments. Contracted rates may not be paid correctly. Without systematic tracking, leakage goes unnoticed and accumulates. Measuring denial rates, days in receivables, and collection against expected reimbursement identifies where financial performance can improve.
Workforce cost and availability
Staffing shortages raise cost and limit capacity.
Read more: Workforce cost and availability
Shortages of nurses, technicians, and other clinical staff increase reliance on contract labor and overtime. Premium labor costs can significantly reduce margin, and unfilled positions may limit the services an organization can offer. Workforce planning tied to volume and revenue helps leaders balance cost, capacity, and quality.
Payer contract performance
Contract rates may not keep pace with costs.
Read more: Payer contract performance
Commercial contracts renew periodically, and government rates are set by fee schedules that may lag inflation. Organizations without clear analysis of contract profitability are at a disadvantage in negotiations. Modeling the financial effect of contract terms supports better decisions about which agreements to renegotiate or exit.
Runway in life sciences
Trial delays extend spending before value inflection points.
Read more: Runway in life sciences
Clinical trials may take longer or cost more than planned, while financing markets fluctuate. Companies that plan runway only to the next milestone risk raising capital on poor terms. Scenario planning for trial delays and cost overruns helps boards act earlier on spending and financing decisions.
Regulatory and compliance cost
Requirements add cost and limit flexibility.
Read more: Regulatory and compliance cost
Healthcare is heavily regulated, and compliance programs, documentation, and reporting requirements add significant administrative cost. Compliance matters remain with qualified professionals and counsel, but financial plans should reflect their cost and the potential effect of rule changes on revenue and operations.
Capital investment and facilities
Facilities and equipment require major long-term commitments.
Read more: Capital investment and facilities
Hospitals, surgery centers, imaging facilities, and laboratories require significant capital for buildings and equipment. Investments must be justified against realistic volume and reimbursement assumptions. Debt capacity, lease alternatives, and partnership structures each affect financial flexibility and long-term returns.
Financial advisory for providers, services, and innovators
Finance & Accounting Advisory
Revenue cycle analytics, reporting, and fractional CFO leadership.
Read more: Finance & Accounting Advisory
Perrin & Co. can improve financial reporting, revenue cycle analytics, contract profitability analysis, and close processes. Interim or fractional CFO leadership is available for providers, services companies, and life sciences businesses. Work addresses finance and operations only and does not include clinical, coding certification, or regulatory compliance services.
Business Advisory
Service line, payer, and capacity decisions.
Read more: Business Advisory
Financial decision support evaluates service line profitability, payer contract economics, staffing productivity, and capital investments. For life sciences companies, analysis covers runway, milestone planning, and commercialization economics. Recommendations are tested against realistic volume and reimbursement scenarios rather than optimistic plans.
Capital Structure & Financing
Borrower-side debt, lease, and refinancing analysis.
Read more: Capital Structure & Financing
Perrin & Co. analyzes debt capacity, facility and equipment financing, lease alternatives, and refinancing options, and supports healthcare organizations in lender discussions as borrower. The firm does not place securities or raise equity, and terms vary by lender and facility.
Technology Solutions
Connecting clinical, billing, and financial systems for reporting.
Read more: Technology Solutions
Perrin & Co.'s Technology Solutions capability can help connect practice management, billing, and accounting systems so revenue cycle and financial data reconcile and reach management promptly. Work concerns financial reporting systems, not clinical record systems or patient care workflows. Clinical systems remain outside scope.
Where to start
- Finance & Accounting AdvisoryReporting, controls, and finance leadership.
- Business AdvisoryStrategic and transaction decisions.
Scope qualification. Perrin & Co. provides financial and operational advisory only. We do not provide clinical, medical coding, reimbursement compliance, regulatory, licensure, or legal advice, and this page does not represent specialized healthcare regulatory credentials. Those matters remain with qualified healthcare counsel and specialists.
Explore Healthcare & Life Sciences
Discuss your healthcare & life sciences priorities
A confidential conversation with Perrin & Co. — no obligation, and a candid view of whether we can help.